Should you drink IGF-1 LR3? What the science says

What did @mason...p actually say?

The creator made two distinct claims in quick succession. First, that taking IGF-1 LR3 orally produces "the same effect" as injecting it. Then, that the same effect is "nothing" because IGF-1 LR3 is useless regardless of how you administer it. To be fair to the creator, the second claim is the one doing real work here. They were not promoting oral IGF-1 LR3 as a hack. They were saying the whole compound is a waste of money, full stop. The framing is intentionally blunt: "whether you pin it or drink it or throw it in the trash, it's going to do the same thing for you." That is a strong position. Let us look at whether the science actually supports it.

Does the science back this up?

On the oral bioavailability point, the creator is correct, and the reasoning is straightforward biochemistry. IGF-1 LR3 is a polypeptide, roughly 83 amino acids long. Proteolytic enzymes in the gastrointestinal tract degrade peptides of this size before systemic absorption can occur, which makes oral administration essentially inert. This is not controversial. Tamaki et al. (2014, Drug Metabolism and Pharmacokinetics) confirmed that large polypeptides face near-complete enzymatic degradation in the GI tract without specialized delivery systems. On the broader "it does nothing" claim, the picture is more complicated. IGF-1 and its analogs have documented anabolic and recovery-related activity in research settings, though almost entirely under subcutaneous or intramuscular injection protocols.

What did they get wrong, and what did they get right?

The creator got the oral bioavailability point exactly right. Drinking a polypeptide and expecting systemic effects is pharmacologically naive, and it is worth saying plainly. Where the claim overshoots is in the sweeping dismissal of injected IGF-1 LR3 as equally useless. That is a harder position to defend. Preclinical studies, including work by Guler et al. (1988, Journal of Clinical Investigation), demonstrated that IGF-1 analogs produce measurable anabolic and metabolic effects in animal models under parenteral administration. Human research is limited and largely in clinical populations, not healthy adults seeking performance benefits, but the compound is not pharmacologically inert when injected. The creator may have been speaking specifically to the context of recreational use with unverified peptide sourcing, which is a legitimate concern, but the blanket "useless when injected" framing is not fully supported.

What should you actually know?

A few things matter here regardless of where you land on the creator's take. First, IGF-1 LR3 is not approved by the FDA for any use in healthy adults, and compounded or gray-market versions have no verified purity or potency standards. Second, the risks associated with supraphysiologic IGF-1 activity, including insulin resistance, acromegalic tissue effects, and theoretical promotion of abnormal cell proliferation, are documented in the literature. Laron (2001, Endocrine Reviews) reviewed IGF-1 pathophysiology extensively. Third, the creator's instinct to warn against oral use is sound. The real concern is that someone watching this might decide injecting it is therefore fine, because at least that route has pharmacological plausibility. That does not make it safe or legal for self-administration.

Bottom line: how accurate is this video overall?

The core practical warning, do not drink IGF-1 LR3 expecting results, is accurate and worth spreading. The extension of that logic to cover injected IGF-1 LR3 as equally pointless is an overstatement that the pharmacological record does not fully support, even if the creator's broader skepticism about recreational peptide use is reasonable. This is a case where the conclusion is defensible but the reasoning cuts corners. In a space where people are making real decisions about unregulated compounds, that distinction matters.